×
For best experience we recommend to activate Javascript in your browser.
Recombinant HAVCR2 (Sabatolimab Biosimilar) antibody
This anti-HAVCR2 (Sabatolimab Biosimilar) antibody is a CHO Cells Monoclonal antibody detecting HAVCR2 (Sabatolimab Biosimilar) in not_set. Suitable for Human.
Catalog No. ABIN7488335
$336.06
Plus shipping costs $50.00
1 mg ABIN7470235
100 μg ABIN7488335
1 mg ABIN7470235
100 μg ABIN7488335
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant HAVCR2 (Sabatolimab Biosimilar) antibody (ABIN7488335)
Target
HAVCR2 (Sabatolimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for HAVCR2 (Sabatolimab Biosimilar) antibodies
CHO Cells
Clonality
All clonalities for HAVCR2 (Sabatolimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for HAVCR2 (Sabatolimab Biosimilar) antibodies
This HAVCR2 (Sabatolimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Product Details anti-HAVCR2 (Sabatolimab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Sabatolimab Biosimilar - Anti-HAVCR2 mAb
Characteristics
Antibody Type: IgG4,Kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG4 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS buffer pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for HAVCR2 (Sabatolimab Biosimilar)
(hide)
Target
HAVCR2 (Sabatolimab Biosimilar)
Target Type
Biosimilar
Background
ANTI-TIM3 CHECKPOINT INHIBITOR MBG453, IMMUNOGLOBULIN G4 (226-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN, DIMER, IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODY, MBG-453,
Recently viewed
(hide)
Chat with us , powered by LiveChat